Who Paid My Doc
Kenneth Lin
Sports Medicine Stanford, CA Medical Doctor
NPI 1417311556 CMS profile 11304589
300 Pasteur Dr, Stanford, CA 94305
General payments
$41,658
Research payments
$48,938
Ownership & investment interest
$0
Through program year 2025, Kenneth Lin of Stanford, CA is reported in the CMS Open Payments database as having received $41,658 across 77 general payments and $48,938 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 91st percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $520 | 8 | |
| 2025 | Research | $48,938 | 1 | |
| 2024 | General | $121 | 2 | |
| 2023 | General | $475 | 6 | |
| 2022 | General | $23,291 | 37 | |
| 2021 | General | $17,251 | 24 |
Beside peers
- Kenneth Lin
- Sports Medicine median
- Middle half of Sports Medicine
- National median
In program year 2025, general payments to Kenneth Lin were reported at $520. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.
Show as a table
| Year | Kenneth Lin | Sports Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $1,176 | $199–$4,249 | $163 |
| 2020 | $0 | $708 | $96–$2,890 | $114 |
| 2021 | $17,251 | $1,213 | $152–$3,994 | $132 |
| 2022 | $23,291 | $1,230 | $159–$3,998 | $149 |
| 2023 | $475 | $584 | $146–$2,836 | $160 |
| 2024 | $121 | $628 | $163–$3,168 | $164 |
| 2025 | $520 | $664 | $172–$3,055 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 42 billing codesPaid by Medicare
$143,551
Medicare patients
309
Services billed
8,238
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 75% | |
| High blood pressure | 59% | |
| Osteoporosis | 23% | |
| Depression | 18% | |
| Cancer | 15% | |
| Diabetes | 14% | |
| Ischemic heart disease | 14% | |
| Chronic kidney disease | 14% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 | Office | 14 | 1,140 | $5,900 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 | Office | 13 | 46 | $4,588 |
| Injection, ropivacaine hydrochloride, 1 mg J2795 | Office | 47 | 5,000 | $261 |
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 24 | 1,280 | $127 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
78 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Sports Medicine in California
Related records
Sports Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Sports Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.